Rationale for Treatment With Momelotinib in Patients With MF

Opinion
Video

Momelotinib, a recently approved treatment for myelofibrosis, targets multiple pathways,and offers a promising approach to improve anemia, especially in patients who did not respond optimally to previous JAK inhibitors.

Related Videos
Related Content